pillbase.ru

Vimpat

Active substance: lacosamide

lacosamide

Centralised EU authorisationActive

Marketing holder: UCB Pharma SA

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 164
  • LACOSAMIDE
    TABLET, FILM COATED · LACOSAMIDE 50 mg/1
    31722-812
    Camber Pharmaceuticals, Inc.
  • LACOSAMIDE
    TABLET, FILM COATED · LACOSAMIDE 200 mg/1
    50228-195
    ScieGen Pharmaceuticals Inc
  • LACOSAMIDE
    TABLET, FILM COATED · LACOSAMIDE 200 mg/1
    67046-1445
    Coupler LLC
  • LACOSAMIDE
    TABLET, FILM COATED · LACOSAMIDE 150 mg/1
    31722-814
    Camber Pharmaceuticals, Inc.
  • LACOSAMIDE
    TABLET, FILM COATED · LACOSAMIDE 150 mg/1
    51991-350
    Breckenridge Pharmaceutical, Inc.
All products in this country (164)
Import and control

Control by country

  • United StatescontrolledSchedule: CV

    Source: openFDA NDC · record 01a1208c-3921-7d85-ae61-589ecc514a7f,01a1208c-4632-76dd-a6e2-c52b402bcb63,01a1208c-4f5f-76f9-b449-eb648790846d,01a1208c-502d-7a0b-b11a-9b07d4ce2dfd,01a1208c-6a8d-70a9-a311-5cc56f3a84a9;count=164 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000863
Registration status
Active
ATC code
N03AX18
Sources
  • product · EMA · EMEA/H/C/000863 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000863 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000863 · Verified 2026-10-09